Jon Pederson, OD
Corneal and Contact Management · Centennial, CONPI 1407842628
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 12 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Glaukos Corporation at 21.6% of the total. 2025 is the largest year on record at $385, more than ten times the $16 reported in 2019. That places this record below the midpoint for corneal and contact management clinicians in CO, where the typical reported total is $654.
Across 12 payments — averaging $62.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Glaukos Corporation$163
- Bausch & Lomb Americas Inc.$162
- Biotissue Holdings Inc.$148
- Carl Zeiss Meditec USA, Inc.$124
- Dompe US, Inc.$100
- Alcon$58
What the payments were for
- Food & beverage$754100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Glaukos Corporation | 1 | $163 |
| Bausch & Lomb Americas Inc. | 3 | $162 |
| Biotissue Holdings Inc. | 3 | $148 |
| Carl Zeiss Meditec USA, Inc. | 1 | $124 |
| Dompe US, Inc. | 1 | $100 |
| Alcon | 3 | $58 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CIRRUS HD-OCT$124
- VYZULTA$122
How this compares
$754 in reported general payments places this provider in the 50th percentile of 33 corneal and contact management providers in Colorado.
See all corneal and contact management providers in Colorado →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 170 | $2,672 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 15 | $1,814 |
| Prednisolone Acetate | 40 | $1,739 |
| Fluorometholone | 21 | $1,362 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 22 | $864 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 37 | $595 |
| ValacyclovirValacyclovir Hcl | 15 | $577 |
| Ketorolac Tromethamine | 16 | $337 |
| Timolol Maleate | 34 | $228 |
| Brimonidine Tartrate | 12 | $39 |
Paid to pharmacies, not to this prescriber.
Other corneal and contact management in Centennial
- John SchachetCentennial$8K
- Vasiliki Alevras-SztukowskiCentennial$1K
- Paul ConklingCentennial$64
- Ryan SmedleyWestminster$88K
- Natalie SantelliFort Collins$5K
- Sarah BellParker$4K
- Grant SchanemanJohnstown$4K
- Kevin AndersonFt Collins$2K
- Jerry BellParker$2K
- Larry EklundWellington$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.